Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001445064-16-000185
Filing Date
2016-01-05
Accepted
2016-01-05 17:20:09
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5544
  Complete submission text file 0001445064-16-000185.txt   6844
Mailing Address DAMASTOWN MULHUDDART DUBLIN L2 15
Business Address DAMASTOWN MULHUDDART DUBLIN L2 15 353 1 8808180
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAXALTA INC., ONE BAXTER PARKWAY DEERFIELD IL 60615
Business Address
LLOYD RONALD K. (Reporting) CIK: 0001644078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 161323657